3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)...

Details 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)... 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)...

C - Chemistry, Metallurgy

07

D

C07D 311/58 (2006.01) A61K 31/35 (2006.01) A61K 31/353 (2006.01) C07D 335/06 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 407/04 (2006.01) C07D 409/04 (2006.01) C07D 409/06 (2006.01) C07D 409/12 (2006.01) C07D 413/04 (2006.01) C07D 413/06 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2118708

2118708 9307135 PCTABS00021 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl)carbamoylchroman having formula (I), as racemate, (R)-enantiomer in the form of free base or pharmaceutically acceptable salts thereof. The object of the present invention is to provide compounds for therapeutic use, especially for treatment of 5-hydroxytryptamine mediated disorders in the central nervous system for instance depression, anxiety, obsessive-compulsive disorder (OCD), anorexia, senile dementia, migraine, stroke, Alzheimer's disease, hypertension, thermoregulatory and sexual disturbances, pain and for treatment of disturbances in the cardiovascular system.

Affiliated with

Also associated with

Rating

3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1982435